Markets:

Overview

News

Currencies

International

Treasuries

NanoViricides, Inc. Common Stock (NY:NNVC)

1.327 +0.006 (+0.49%)

Delayed Quote Updated: 12:04 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NanoViricides, Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 15, 2021

Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!

Via InvestorPlace

NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2

November 15, 2021

SHELTON, CT / ACCESSWIRE / November 15, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel...

From NanoViricides, Inc.

Via AccessWire

EXCLUSIVE: NanoViricides Develops Chewable Pills, Lung Inhalation Formulations For COVID-19 Candidate ↗

November 15, 2021

NanoViricides Inc (NYSE: NNVC) has developed oral gummies formulations of its Pan-Coronavirus COVID-19 Drug Candidate NV-CoV-2 to benefit non-hospitalized patients. What...

Via Benzinga

Todos Medical Says It Wants to Outfox COVID-19 & Cancer Along With Rivals Pfizer & Merck With New Theranostic Approach ↗

November 05, 2021

Photo by Artem Podrez from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Are Pfizer, Moderna, J&J Booster Shots a Panacea? This Company Says Its Broad-Spectrum Drugs to Fight COVID-19 Would Help End the Pandemic ↗

November 02, 2021

Photo by Steven Cornfield on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage

October 13, 2021

SHELTON, CT / ACCESSWIRE / October 13, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2021...

From NanoViricides, Inc.

Via AccessWire

Topics Intellectual Property Regulatory Compliance

NanoViricides COVID-19 Treatment Candidate Found Effective Against Coronavirus Variants In Lab Study ↗

October 11, 2021

Shares of NanoViricides Inc (NYSE: NNVC), a developer of antiviral therapies based on a novel nanomedicines technology, are higher Monday. What Happened: NanoViricides...

Via Benzinga

Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

October 11, 2021

Palm Beach, FL –October 11, 2021 – FinancialNewsMedia.com News Commentary – With the arrival of the COVID-19 virus, the antivirals market had all eyes watching the ongoing frenetic rush to find a cure...

Via FinancialNewsMedia

NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity ↗

October 11, 2021

Shelton, Connecticut -- (October 11, 2021) - NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral...

Via Benzinga

NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity

October 11, 2021

SHELTON, CT / ACCESSWIRE / October 11, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel...

From NanoViricides, Inc.

Via AccessWire

NanoViricides Leaps Forward in its Quest to Defeat COVID-19 ↗

October 05, 2021

Photo by Louis Reed on Unsplash Since the coronavirus pandemic started, scientists have worked to develop a vaccine to inoculate the population and stop the spread of COVID-19....

Via Benzinga

31 Stocks Moving In Monday's Mid-Day Session ↗

September 27, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to...

Via Benzinga

20 Stocks Moving in Monday's Pre-Market Session ↗

September 27, 2021

Gainers Puhui Wealth Investment Management Co., Ltd. (NASDAQ: PHCF) rose 49% to $3.65 in pre-market trading. Paltalk, Inc. (NASDAQ: PALT) rose 43.9% to $5.77 in pre-market...

Via Benzinga

50 Biggest Movers From Yesterday ↗

September 23, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a...

Via Benzinga

32 Stocks Moving In Wednesday's Mid-Day Session ↗

September 22, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share...

Via Benzinga

Nanoviricides Stock Surges, Nears The End Of A Pennant Pattern ↗

September 21, 2021

Nanoviricides Inc. (NYSE:NNVC) shares are surging higher Tue...

Via Benzinga

What Is a ‘News Pending’ Halt? What to Know as NNVC Stock Captivates Investors ↗

September 21, 2021

Today, NanoViricides is grabbing a lot of attention due to a news pending halt that has sent NNVC stock skyrocketing.

Via InvestorPlace

EXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile ↗

September 21, 2021

NanoViricides Inc (NYSE: NNVC) has reported significant advantages gained by remdesivir encapsulation within its lead COVID-19 candidate, thus showing a potential pan-...

Via Benzinga

53 Biggest Movers From Yesterday ↗

September 16, 2021

Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation...

Via Benzinga

Topics Initial Public Offering

38 Stocks Moving In Wednesday's Mid-Day Session ↗

September 15, 2021

Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of...

Via Benzinga

Topics Intellectual Property

26 Stocks Moving in Wednesday's Pre-Market Session ↗

September 15, 2021

Gainers Nxt-ID, Inc. (NASDAQ: NXTD) rose 46.1% to $0.6699 in pre-market trading after dropping 11% on Tuesday. MeaTech 3D Ltd. (NASDAQ: MITC) rose 18.5% to $6.29 in pre-market...

Via Benzinga

46 Biggest Movers From Yesterday ↗

September 15, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...

Via Benzinga

Why Nanoviricides' Stock Is Trading Higher Today ↗

September 14, 2021

Nanoviricides (AMEX:NNVC) shares are trading higher after the company announced it completed the process of licensing the human Coronavirus field for drug development and...

Via Benzinga

36 Stocks Moving In Tuesday's Mid-Day Session ↗

September 14, 2021

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...

Via Benzinga

20 Stocks Moving in Tuesday's Pre-Market Session ↗

September 14, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share. DatChat, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

EXCLUSIVE: NanoViricides Beefs Up Its COVID-19 Pipeline With TheraCour Licensing Pact ↗

September 14, 2021

NanoViricides Inc (NYSE: NNVC) has in-licensed oral antiviral candidates targeting COVID-19 and variants from TheraCour Pharma Inc. The Company executed a license agreement on...

Via Benzinga

62 Biggest Movers From Yesterday ↗

July 29, 2021

Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to...

Via Benzinga

Topics Cannabis

50 Stocks Moving In Wednesday's Mid-Day Session ↗

July 28, 2021

Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the...

Via Benzinga

62 Biggest Movers From Yesterday ↗

July 28, 2021

Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

NanoViricides, Inc. Common Stock (NY:NNVC)

All News about NanoViricides, Inc. Common Stock

Resources